Cover Image
Market Research Report

Europe Stroke Management Market (2018 - 2024)

Published by KBV Research Product code 763781
Published Content info 98 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Stroke Management Market (2018 - 2024)
Published: December 20, 2018 Content info: 98 Pages
Description

The Europe Stroke Management Market would witness market growth of 6.7% CAGR during the forecast period (2018 - 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advanced devices and drugs would limit the market growth.

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Stroke Management Market, by Type
    • 1.4.2 Europe Stroke Management Market, by Application
    • 1.4.3 Europe Stroke Management Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Players Outlook for the Market
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Europe Stroke Management Market by Type

    • 3.1.1 Europe Diagnostics Stroke Management Market by Country
      • 3.1.1.1 Europe Stroke Management Market by Diagnostics Type
        • 3.1.1.1.1 Europe Stroke Management Computed Tomography Scan (CT Scan) Market by Country
        • 3.1.1.1.2 Europe Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
        • 3.1.1.1.3 Europe Stroke Management Echocardiography Market by Country
        • 3.1.1.1.4 Europe Stroke Management Carotid Ultrasound Market by Country
        • 3.1.1.1.5 Europe Stroke Management Cerebral Angiography Market by Country
        • 3.1.1.1.6 Europe Stroke Management Electrocardiography Market by Country
        • 3.1.1.1.7 Europe Other Diagnostics Type Stroke Management Market by Country
    • 3.1.2 Europe Therapeutics Stroke Management Market by Country
      • 3.1.2.1 Europe Stroke Management Market by Therapeutics Type
        • 3.1.2.1.1 Europe Tissue Plasminogen Activator Stroke Management Market by Country
        • 3.1.2.1.2 Europe Anticoagulant Stroke Management Market by Country
        • 3.1.2.1.3 Europe Antiplatelet Stroke Management Market by Country
        • 3.1.2.1.4 Europe Other Therapeutics Type Stroke Management Market by Country

Chapter 4. Europe Stroke Management Market by Application

    • 4.1.1 Europe Ischemic Stroke Management Market by Country
    • 4.1.2 Europe Haemorrhagic Stroke Management Market by Country

Chapter 5. Europe Stroke Management Market by Country

  • 5.1 Germany Stroke Management Market
    • 5.1.1 Germany Stroke Management Market by Type
      • 5.1.1.1 Germany Stroke Management Market by Diagnostics Type
      • 5.1.1.2 Germany Stroke Management Market by Therapeutics Type
    • 5.1.2 Germany Stroke Management Market by Application
  • 5.2 UK Stroke Management Market
    • 5.2.1 UK Stroke Management Market by Type
      • 5.2.1.1 UK Stroke Management Market by Diagnostics Type
      • 5.2.1.2 UK Stroke Management Market by Therapeutics Type
    • 5.2.2 UK Stroke Management Market by Application
  • 5.3 France Stroke Management Market
    • 5.3.1 France Stroke Management Market by Type
      • 5.3.1.1 France Stroke Management Market by Diagnostics Type
      • 5.3.1.2 France Stroke Management Market by Therapeutics Type
    • 5.3.2 France Stroke Management Market by Application
  • 5.4 Russia Stroke Management Market
    • 5.4.1 Russia Stroke Management Market by Type
      • 5.4.1.1 Russia Stroke Management Market by Diagnostics Type
      • 5.4.1.2 Russia Stroke Management Market by Therapeutics Type
    • 5.4.2 Russia Stroke Management Market by Application
  • 5.5 Spain Stroke Management Market
    • 5.5.1 Spain Stroke Management Market by Type
      • 5.5.1.1 Spain Stroke Management Market by Diagnostics Type
      • 5.5.1.2 Spain Stroke Management Market by Therapeutics Type
    • 5.5.2 Spain Stroke Management Market by Application
  • 5.6 Italy Stroke Management Market
    • 5.6.1 Italy Stroke Management Market by Type
      • 5.6.1.1 Italy Stroke Management Market by Diagnostics Type
      • 5.6.1.2 Italy Stroke Management Market by Therapeutics Type
    • 5.6.2 Italy Stroke Management Market by Application
  • 5.7 Rest of Europe Stroke Management Market
    • 5.7.1 Rest of Europe Stroke Management Market by Type
      • 5.7.1.1 Rest of Europe Stroke Management Market by Diagnostics Type
      • 5.7.1.2 Rest of Europe Stroke Management Market by Therapeutics Type
    • 5.7.2 Rest of Europe Stroke Management Market by Application

Chapter 6. Company Profiles

  • 6.1 B. Braun Melsungen AG.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 ABBOTT
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional & Segmental Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Cardinal Health
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental Analysis
  • 6.4 Medtronic Plc.
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental and Regional Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 General Electric (GE) (GE Healthcare)
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Segmental and Regional Analysis
    • 6.5.4 Research & Development Expense
  • 6.6 Siemens Healthineers
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Bristol-Myers Squibb
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Merck & Company Inc.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental Analysis
    • 6.8.4 Research & Development Expense
  • 6.9 Glaxosmithkline Plc.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental Analysis
    • 6.9.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 EUROPE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 2 EUROPE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 3 EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 4 EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 5 EUROPE DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 6 EUROPE DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 7 EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 8 EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 9 EUROPE STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 10 EUROPE STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 11 EUROPE STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 12 EUROPE STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 13 EUROPE STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 14 EUROPE STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 15 EUROPE STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 16 EUROPE STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 17 EUROPE STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 18 EUROPE STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 19 EUROPE STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 20 EUROPE STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 21 EUROPE OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 22 EUROPE OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 23 EUROPE THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 24 EUROPE THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 25 EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 26 EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 27 EUROPE TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 28 EUROPE TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 29 EUROPE ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 30 EUROPE ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 31 EUROPE ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 32 EUROPE ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 33 EUROPE OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 34 EUROPE OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 35 EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 36 EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 37 EUROPE ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 38 EUROPE ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 39 EUROPE HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 40 EUROPE HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 41 EUROPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 42 EUROPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 43 GERMANY STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 44 GERMANY STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 45 GERMANY STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 46 GERMANY STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 47 GERMANY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 48 GERMANY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 49 GERMANY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 50 GERMANY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 51 GERMANY STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 52 GERMANY STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 53 UK STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 54 UK STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 55 UK STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 56 UK STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 57 UK STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 58 UK STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 59 UK STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 60 UK STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 61 UK STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 62 UK STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 63 FRANCE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 64 FRANCE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 65 FRANCE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 66 FRANCE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 67 FRANCE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 68 FRANCE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 69 FRANCE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 70 FRANCE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 71 FRANCE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 72 FRANCE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 73 RUSSIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 74 RUSSIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 75 RUSSIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 76 RUSSIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 77 RUSSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 78 RUSSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 79 RUSSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 80 RUSSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 81 RUSSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 82 RUSSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 83 SPAIN STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 84 SPAIN STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 85 SPAIN STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 86 SPAIN STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 87 SPAIN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 88 SPAIN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 89 SPAIN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 90 SPAIN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 91 SPAIN STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 92 SPAIN STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 93 ITALY STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 94 ITALY STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 95 ITALY STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 96 ITALY STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 97 ITALY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 98 ITALY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 99 ITALY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 100 ITALY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 101 ITALY STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 102 ITALY STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 103 REST OF EUROPE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 104 REST OF EUROPE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 105 REST OF EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 106 REST OF EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 107 REST OF EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 108 REST OF EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 109 REST OF EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 110 REST OF EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 111 REST OF EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 112 REST OF EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 113 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 114 KEY INFORMATION - ABBOTT
  • TABLE 115 KEY INFORMATION - CARDINAL HEALTH
  • TABLE 116 BUSINESS SEGMENT - CARDINAL HEALTH
  • TABLE 117 KEY INFORMATION - MEDTRONIC PLC
  • TABLE 118 KEY INFORMATION - MEDTRONIC
  • TABLE 119 KEY INFORMATION - GENERAL ELECTRIC (GE)
  • TABLE 120 KEY INFORMATION - SIEMENS HEALTHINEERS
  • TABLE 121 KEY INFORMATION - BRISTOL-MYERS SQUIBB
  • TABLE 122 KEY INFORMATION - MERCK & COMPANY INC.
  • TABLE 123 KEY INFORMATION - GLAXOSMITHKLINE PLC.
Back to Top